Campest-5-en-3-one, an oxidized derivative of campesterol, activates PPARα, promotes energy consumption and reduces visceral fat deposition in rats
| Autor: | Takeshi Shimizu, Hiroko Tomoyori, Kunio Suzuki, Koji Nagao, Nao Inoue, Nobuyuki Takahashi, Teruyoshi Yanagita, Rie Konno, Katsumi Imaizumi, Tadateru Hamada, Yae Morinaga, Ikuo Ikeda, Teruo Kawada, Takashi Ide |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Male
medicine.medical_specialty Campesterol Biophysics Malic enzyme Peroxisome proliferator-activated receptor Intra-Abdominal Fat Biology Biochemistry Feces chemistry.chemical_compound Internal medicine medicine Animals PPAR alpha RNA Messenger Molecular Biology Fatty acid synthesis chemistry.chemical_classification Cholesterol Body Weight Fatty Acids Phytosterols Rats Inbred Strains Lipid metabolism Peroxisome Sterol Rats Endocrinology Liver chemistry Steroids Energy Metabolism Oxidoreductases Sterol Regulatory Element Binding Protein 1 Oxidation-Reduction |
| Zdroj: | Biochimica et Biophysica Acta (BBA) - General Subjects. 1760:800-807 |
| ISSN: | 0304-4165 |
| DOI: | 10.1016/j.bbagen.2006.02.017 |
| Popis: | Dietary campest-5-en-3-one (campestenone), an oxidized derivative of campesterol, significantly reduced visceral fat weight and the concentration of triacylglycerol in serum and liver of rats. Dietary campestenone dramatically increased the activities and the mRNA expressions of mitochondrial and peroxisomal enzymes involved in beta-oxidation in the liver. Campestenone activated human peroxisome proliferator-activated receptor (PPAR) alpha as determined using the novel GAL4 ligand-binding domain chimera assay system with coactivator coexpression. In contrast, dietary campestenone reduced the activities and the mRNA expressions of enzymes involved in fatty acid synthesis, except for the malic enzyme. Dietary campestenone decreased the sterol regulatory element binding protein-1 (SREBP-1) mRNA level. Energy expenditure was significantly higher in the feeding of campestenone in rats. Dietary campestenone reduced hepatic cholesterol concentration and increased fecal excretion of neutral steroids originated from cholesterol. Lymphatic absorption of cholesterol was reduced by the coadministration of campestenone in rats cannulated in the thoracic duct. These observations suggest a possibility that campestenone has an ability to prevent coronary heart disease by improving obesity and abnormality of lipid metabolism. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect